The Claim
Dysbiosis of the gut microbiota reduces secondary bile acid production, leading to impaired activation of TGR5 and FXR receptors in the liver and kidneys, which results in increased inflammation and reduced mitochondrial function, thereby promoting the progression of diabetic kidney disease.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Changes in gut bacteria reduce the production of certain bile acids, which decreases activation of receptors in the liver and kidneys that normally reduce inflammation and support energy production in cells, contributing to worsening kidney damage in diabetes.
See the scientific wording
The gut microbiota’s role in bile acid metabolism influences diabetic kidney disease progression, as dysbiosis reduces secondary bile acid production, impairing activation of protective TGR5 and FXR receptors in the liver and kidneys, which normally suppress inflammation and enhance mitochondrial function.
Bad gut bacteria in people with diabetes produce fewer protective bile acids, which normally turn on safety switches in the liver and kidneys called TGR5 and FXR. When these switches are off, the kidneys can't control inflammation or fix damaged energy factories, causing kidney damage to get worse.
What the research says
1 studyThe study shows that bad gut bacteria in people with diabetic kidney disease make harmful substances that hurt the kidneys and cause inflammation — which matches the idea that good gut bacteria normally make protective chemicals that keep kidneys safe.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.